RxDoctor Payments Data

Richard Perry, DO

Family Medicine · Sanger, TXNPI 1689687360

Payments from drug & device makers

$463in general payments, 2019–2025

Across 27 payments — averaging $17.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Antares Pharma, Inc.$110
  • Lilly USA, LLC$61
  • Halozyme Inc$43
  • Lundbeck LLC$41
  • GSK$36
  • Novo Nordisk$31
  • plus $141 from 8 others

What the payments were for

  • Food & beverage$463100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$463 in reported general payments places this provider in the 50th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$77,928
Medicare patients
210
Services billed
2,344

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide80$137,866
JanuviaSitagliptin Phosphate93$80,678
MounjaroTirzepatide37$67,331
BiktarvyBictegrav/Emtricit/Tenofov Ala11$50,594
EliquisApixaban40$46,966
TrulicityDulaglutide15$29,141
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$22,150
XareltoRivaroxaban13$12,649
Tresiba Flextouch U-100Insulin Degludec15$8,598
Albuterol Sulfate HfaAlbuterol Sulfate124$4,990
Gabapentin218$4,710
Lantus SolostarInsulin Glargine,hum.Rec.Anlog22$4,428
Fluticasone-SalmeterolFluticasone Propion/Salmeterol16$3,537
Atorvastatin Calcium417$3,090
Duloxetine Hcl115$2,950

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$31$137,86680 claims
Lilly USA, LLCMounjaro, Trulicity$61$96,47252 claims
GSKTrelegy Ellipta$36$22,15019 claims
Johnson & JohnsonXarelto$14$12,64913 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Sanger

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →